NCT01592864

Brief Summary

A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over an eight week treatment period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Mar 2012

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 3, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 7, 2012

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

March 10, 2014

Completed
Last Updated

March 10, 2014

Status Verified

December 1, 2013

Enrollment Period

2 months

First QC Date

May 3, 2012

Results QC Date

May 16, 2013

Last Update Submit

February 6, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Week 8

    Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus.

    Baseline to 8 weeks post administration of study treatment

Secondary Outcomes (3)

  • Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Week 4

    Baseline to 4 weeks post administration of study treatment

  • Adjusted Mean Change From Baseline in Tactile Sensitivity Pain Response at Week 8

    Baseline to 8 weeks post administration of study treatment

  • Adjusted Mean Change From Baseline in Tactile Sensitivity Pain Response at Week 4

    Baseline to 4 weeks post administration of study treatment

Study Arms (2)

Arm 1

EXPERIMENTAL

Dentifrice containing stannous fluoride

Drug: Stannous Fluoride

Arm 2

ACTIVE COMPARATOR

Marketed dentifrice containing Sodium Monofluorophosphate

Drug: Sodium Monofluorophosphate

Interventions

dentifice

Arm 1

dentifrice

Arm 2

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects who suffer from tooth sensitivity
  • \- none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BioSci Research America, Inc.

Las Vegas, Nevada, 89121, United States

Location

MeSH Terms

Conditions

Dentin Sensitivity

Interventions

Tin Fluoridesfluorophosphate

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

FluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsTin CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
GSK Response Center
Organization
GlaxoSmithKline

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2012

First Posted

May 7, 2012

Study Start

March 1, 2012

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

March 10, 2014

Results First Posted

March 10, 2014

Record last verified: 2013-12

Locations